Upstream Bio
Price & Volume
Stats
See moreOpen | $7.02 |
Previous Close | $7.18 |
Day Range | $6.91-$7.19 |
52W Range | $5.85-$33.68 |
Market Cap | $393.2M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $3.1M |
Revenue Growth (YoY) | -17.5% |
Gross Profit (12 Mos) | $3.1M |
Diluted EPS | -$3.14 |
News
See moreYahoo Finance • 2 months ago
Is Upstream Bio, Inc. (UPB) the Best Low Priced Stocks to Get Rich in 2026?
Yahoo Finance • 2 months ago
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
Yahoo Finance • 3 months ago
Upstream Bio, Inc. reports Q1 results
Yahoo Finance • 4 months ago
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
About
CEO | Dr. E. Rand Sutherland M.D., M.P.H. |
CFO | Mr. Michael Paul Gray CPA, MBA |
Address | 890 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 75 |